JP2013515015A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013515015A5 JP2013515015A5 JP2012545030A JP2012545030A JP2013515015A5 JP 2013515015 A5 JP2013515015 A5 JP 2013515015A5 JP 2012545030 A JP2012545030 A JP 2012545030A JP 2012545030 A JP2012545030 A JP 2012545030A JP 2013515015 A5 JP2013515015 A5 JP 2013515015A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- polypeptide
- immunogenic
- pharmaceutically acceptable
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 44
- 229920001184 polypeptide Polymers 0.000 claims 27
- 108090000765 processed proteins & peptides Proteins 0.000 claims 27
- 102000004196 processed proteins & peptides Human genes 0.000 claims 27
- 230000002163 immunogen Effects 0.000 claims 24
- 239000000546 pharmaceutical excipient Substances 0.000 claims 18
- 101710183389 Pneumolysin Proteins 0.000 claims 13
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 10
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims 8
- 101100420868 Anuroctonus phaiodactylus phtx gene Proteins 0.000 claims 4
- 239000002671 adjuvant Substances 0.000 claims 4
- 229960005486 vaccine Drugs 0.000 claims 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 239000000839 emulsion Substances 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 239000000600 sorbitol Substances 0.000 claims 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical group Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims 2
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims 2
- 230000005847 immunogenicity Effects 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 239000002736 nonionic surfactant Substances 0.000 claims 2
- 229920002704 polyhistidine Polymers 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 235000000346 sugar Nutrition 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 208000031729 Bacteremia Diseases 0.000 claims 1
- 206010010741 Conjunctivitis Diseases 0.000 claims 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical group OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- 239000007995 HEPES buffer Substances 0.000 claims 1
- 201000009906 Meningitis Diseases 0.000 claims 1
- 108010038807 Oligopeptides Proteins 0.000 claims 1
- 102000015636 Oligopeptides Human genes 0.000 claims 1
- 206010033078 Otitis media Diseases 0.000 claims 1
- 208000035109 Pneumococcal Infections Diseases 0.000 claims 1
- 206010035664 Pneumonia Diseases 0.000 claims 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims 1
- 150000005215 alkyl ethers Chemical class 0.000 claims 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 239000003125 aqueous solvent Substances 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 239000006172 buffering agent Substances 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 235000014633 carbohydrates Nutrition 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003599 detergent Substances 0.000 claims 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 150000002170 ethers Chemical class 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000002831 pharmacologic agent Substances 0.000 claims 1
- 229920001308 poly(aminoacid) Polymers 0.000 claims 1
- -1 polyoxyethylene Polymers 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 229940031439 squalene Drugs 0.000 claims 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 150000005846 sugar alcohols Polymers 0.000 claims 1
- 150000008163 sugars Chemical class 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28923609P | 2009-12-22 | 2009-12-22 | |
| US61/289,236 | 2009-12-22 | ||
| US32566010P | 2010-04-19 | 2010-04-19 | |
| US61/325,660 | 2010-04-19 | ||
| PCT/CA2010/001977 WO2011075823A1 (en) | 2009-12-22 | 2010-12-20 | Immunogenic compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015254259A Division JP2016104776A (ja) | 2009-12-22 | 2015-12-25 | 免疫原性組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013515015A JP2013515015A (ja) | 2013-05-02 |
| JP2013515015A5 true JP2013515015A5 (enExample) | 2015-01-29 |
| JP5894083B2 JP5894083B2 (ja) | 2016-03-23 |
Family
ID=44194860
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012545030A Expired - Fee Related JP5894083B2 (ja) | 2009-12-22 | 2010-12-20 | 免疫原性組成物 |
| JP2015254259A Pending JP2016104776A (ja) | 2009-12-22 | 2015-12-25 | 免疫原性組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015254259A Pending JP2016104776A (ja) | 2009-12-22 | 2015-12-25 | 免疫原性組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20130183350A1 (enExample) |
| EP (1) | EP2515938A4 (enExample) |
| JP (2) | JP5894083B2 (enExample) |
| KR (1) | KR20120107121A (enExample) |
| CN (1) | CN102802664B (enExample) |
| AR (1) | AR079712A1 (enExample) |
| AU (1) | AU2010335970B2 (enExample) |
| BR (1) | BR112012018343A2 (enExample) |
| CA (1) | CA2783955A1 (enExample) |
| IL (2) | IL220576B (enExample) |
| WO (1) | WO2011075823A1 (enExample) |
| ZA (1) | ZA201204628B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2784447A1 (en) | 2009-12-22 | 2011-06-30 | Sanofi Pasteur Limited | Adjuvanted immunogenic compositions and related methods |
| CA2819758A1 (en) | 2010-12-03 | 2012-06-07 | Sanofi Pasteur Limited | Composition for immunization against streptococcus pneumoniae |
| BR112013029514A2 (pt) | 2011-05-17 | 2019-09-24 | Glaxosmithkline Biologicals Sa | composição imunogênica, vacina, e, método de tratar ou impedir uma doença |
| GB201218660D0 (en) | 2012-10-17 | 2012-11-28 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| CN104853768B (zh) * | 2012-10-17 | 2019-04-19 | 葛兰素史密丝克莱恩生物有限公司 | 免疫原性组合物 |
| CA2894903A1 (en) * | 2012-12-14 | 2014-06-19 | Sanofi Pasteur, Ltd. | Methods for assessing immunogenicity |
| EP3116537A4 (en) * | 2014-03-10 | 2017-09-13 | Sanofi Pasteur Limited | Immunogenic compositions |
| KR101688960B1 (ko) * | 2014-06-11 | 2016-12-23 | 전남대학교산학협력단 | 스쿠티카충 백신 조성물 |
| JP2018502927A (ja) * | 2015-01-27 | 2018-02-01 | スリーエム イノベイティブ プロパティズ カンパニー | マイクロニードルワクチンパッチ用ミョウバン含有コーティング製剤 |
| GB2556002B (en) * | 2015-07-07 | 2020-12-16 | Bluewillow Biologics Inc | Methods and compositions for nanoemulsion vaccine formulations |
| EP3736574A1 (en) * | 2019-05-07 | 2020-11-11 | Atlas Antibodies AB | A formulation comprising an isotope labeled fusion polypeptide |
| WO2023034932A1 (en) * | 2021-09-02 | 2023-03-09 | Vaxcyte, Inc. | Stabilization of adjuvanted vaccine compositions and their use |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUT58804A (en) * | 1988-12-16 | 1992-03-30 | James Cleland Paton | Process for producing pneumolysine mutants and pneumococcus vaccines |
| US6800744B1 (en) * | 1997-07-02 | 2004-10-05 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| DK1140157T3 (da) * | 1998-12-21 | 2009-06-08 | Medimmune Inc | Streptococcus pneumoniae-proteiner og immunogene fragmenter til vacciner |
| GB0022742D0 (en) * | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
| GB0213622D0 (en) * | 2002-06-13 | 2002-07-24 | Glaxosmithkline Biolog Sa | Vaccine Corporation |
| GB0410220D0 (en) * | 2004-05-07 | 2004-06-09 | Kirkham Lea Ann | Mutant pneumolysin proteins |
| EP1863529A1 (en) * | 2005-03-23 | 2007-12-12 | GlaxoSmithKline Biologicals S.A. | Novel composition |
| TWI457133B (zh) * | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
| AU2007285775B2 (en) * | 2006-08-17 | 2011-03-03 | Sanofi Pasteur Ltd. | Immunogenic PcpA polypeptides and uses thereof |
| AU2008280799B2 (en) | 2007-07-23 | 2013-07-11 | Sanofi Pasteur Limited | Immunogenic polypeptides and monoclonal antibodies |
| AU2009208299B2 (en) * | 2008-02-01 | 2015-01-22 | Sanofi Pasteur Limited | Assay for diagnosing streptococcus pneumoniae |
| BRPI0923649A2 (pt) * | 2008-12-24 | 2016-01-19 | Netherlands Vaccine Inst | polipeptídeos de pneumolisina (ply) de streptococcus pneumoniae modificados. |
-
2010
- 2010-12-20 US US13/515,093 patent/US20130183350A1/en not_active Abandoned
- 2010-12-20 WO PCT/CA2010/001977 patent/WO2011075823A1/en not_active Ceased
- 2010-12-20 CA CA2783955A patent/CA2783955A1/en not_active Abandoned
- 2010-12-20 BR BR112012018343A patent/BR112012018343A2/pt not_active IP Right Cessation
- 2010-12-20 JP JP2012545030A patent/JP5894083B2/ja not_active Expired - Fee Related
- 2010-12-20 CN CN201080064532.1A patent/CN102802664B/zh not_active Expired - Fee Related
- 2010-12-20 EP EP10838456.1A patent/EP2515938A4/en not_active Withdrawn
- 2010-12-20 KR KR1020127019061A patent/KR20120107121A/ko not_active Abandoned
- 2010-12-20 AU AU2010335970A patent/AU2010335970B2/en not_active Ceased
- 2010-12-22 AR ARP100104897A patent/AR079712A1/es unknown
-
2012
- 2012-06-21 ZA ZA2012/04628A patent/ZA201204628B/en unknown
- 2012-06-21 IL IL220576A patent/IL220576B/en not_active IP Right Cessation
-
2015
- 2015-11-15 IL IL242592A patent/IL242592A/en not_active IP Right Cessation
- 2015-12-25 JP JP2015254259A patent/JP2016104776A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013515015A5 (enExample) | ||
| US12083173B2 (en) | Protein antigens that provide protection against pneumococcal colonization and/or disease | |
| US11084850B2 (en) | Recombinant prefusion RSV F proteins and uses thereof | |
| CN102802664B (zh) | 免疫原性组合物 | |
| JP2011514337A5 (enExample) | ||
| JP2010539172A5 (enExample) | ||
| CA2680193C (en) | Lyophilized preparation comprising influenza vaccine, and method for preparation thereof | |
| WO2014018904A1 (en) | Fused antigen vaccines and compositions against streptococcus pneumoniae | |
| CN104023744A (zh) | 用于针对金黄色葡萄球菌免疫的稳定组合物 | |
| RU2014151424A (ru) | Термостабильные составы вакцины | |
| KR20110091560A (ko) | 글루타밀 ｔＲＮＡ 합성효소(ＧｔＳ) 단편들 | |
| JP2017505624A (ja) | 新規治療法 | |
| EP2804627B1 (en) | Fused antigen vaccines and compositions against streptococcus pneumoniae | |
| WO2015049633A1 (es) | FORMULACION INMUNOGENICA QUE CONTIENE BCG VIVAS RECOMBINANTES QUE EXPRESAN ANTIGENOS DE METAPNEUMOVIRUS (hMPV), EN UNA SUSPENSION QUE SE PREPARA A PARTIR DE UN LIOFILIZADO SIN LA NECESIDAD DE ADJUVANTE, APTA PARA SU USO FARMACEUTICO. | |
| Lu et al. | Systemic and mucosal immune responses elicited by intranasal immunization with a pneumococcal bacterium-like particle-based vaccine displaying pneumolysin mutant Plym2 | |
| US20220152182A1 (en) | Vaccine | |
| US20140314812A1 (en) | Live, attenuated streptococcus pneumoniae strain and vaccine for protection against pneumococcal disease | |
| WO2015136374A2 (en) | Immunogenic compositions |